The Latest Breaking News from Medicare

Inflation has surged to multi-year highs, so the Fed is contemplating raising interest rates aggressively this year. And an increasing interest rate environment typically translates to revenue growth for financial companies, including insurers. Thus, we think it could be wise to bet on quality insurance stocks Cigna (CI), Humana (HUM),…

More than $80 million will be spent on genetic testing for those planning pregnancy, while $58 million will be spent on endometriosis treatment.

Widowed and usually living alone, Gloria Bailey walks with a cane after two knee replacement surgeries and needs help with housekeeping.

It's a question many Australians are asking when confronted with their private health insurance payments these days: Why are the premiums so high? The answer is complex.

Rick Scott believes he can get elected president on a program of making inequality great again. He may be right

Medicare has proposed limiting coverage of Aduhelm. Key groups representing patients and families are pressing to make it more widely available. Among people facing the disease, the outlook is more nuanced.

Legislation to limit insulin costs for people with diabetes is getting a new push in the Senate

UnitedHealthcare has added Kala Pharmaceuticals Inc's (NASDAQ:KALA) Eysuvis (loteprednol etabonate ophthalmic suspension) 0.25% as a covered brand on its commercial formularies effective March 2022.  Eysuvis now has coverage for approximately 118 million lives or 70% of all commercial lives. Kala also announced that Cigna Medicare had added Eysuvis as a preferred brand effective…

Health Minister Greg Hunt says the government remains committed to Medicare with almost nine out 10 GP visits provided with no out-of-pocket cost.